跳至主要内容
临床试验/IRCT20120215009014N516
IRCT20120215009014N516尚未招募3 期

Effect of discontinuing immune-modulating drugs versus control group on prognosis in patients with relapsing-remitting multiple sclerosis: a single-blind randomized clinical trial

Hamedan University of Medical Sciences0 个研究点目标入组 178 人开始时间: 待定最近更新:
适应症

试验速览

阶段
3 期
状态
尚未招募
入组人数
178

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

年龄范围
55 years 至 80 years(—)
性别
All

入选标准

  • Age 55 to 80 years
  • Relapsing-remitting multiple sclerosis
  • Taking drugs that modulate the immune system

排除标准

  • Disease attack in the last 5 years
  • Taking Tysabri or Fingolimod drugs

研究者

相似试验

已完成
不适用
COntinuation Versus Interruption of Immunomodulating Drugs in case of an Infectious disease in immune mediated inflammatory disease (IMID) patients, with special attention for COVID-19Immune mediated inflammatory diseasesautoimmune diseases100179691000381610023213
NL-OMON54899Sint Maartenskliniek2,200
已完成
4 期
COntinuation Versus Interruption of Immunomodulating Drugs in case of an Infectious disease in IMID patients (COVID I2 study), with special attention for COVID 19: a pragmatic, explorative randomized controlled trial<p>Rheumatoid arthritis<br />Psoriatic arthritis<br />Axial spondyloarthritis<br />Immune mediated inflammatory diseases<br />Inflammatory rheumatic diseases</p>10003816
NL-OMON22848Sint Maartenskliniek2,200
招募中
1 期
Maintaining or Stopping immunosuppressive Therapy in patients with ANCA vasculitis and End-stage Renal disease: a prospective, multicenter, randomized, open-label, clinical trialANCA vasculitis, End-stage Renal disease
CTIS2024-512470-10-00Centre Hospitalier Departemental Vendee136
招募中
4 期
Maintaining or Stopping immunosuppressive Therapy in patients with ANCA vasculitis and End-stage Renal disease: a prospective, multicenter, randomized, open-label, clinical trial
2024-512470-10-00Centre Hospitalier Departemental Vendee136
进行中(未招募)
不适用
Evaluation de l’arrêt du traitement immunosuppresseur d’entretien après 2 ans dans les glomérulonéphrites lupiques prolifératives - etude WIN LUPUS
EUCTR2010-022859-30-FRASSISTANCE PUBLIQUE HOPITAUX DE MARSEILLE